Xylem Inc.
XYL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,268 | $2,301 | $2,069 | $2,256 |
| % Growth | -1.4% | 11.2% | -8.3% | – |
| Cost of Goods Sold | $1,385 | $1,409 | $1,301 | $1,399 |
| Gross Profit | $883 | $892 | $768 | $857 |
| % Margin | 38.9% | 38.8% | 37.1% | 38% |
| R&D Expenses | $52 | $58 | $56 | $58 |
| G&A Expenses | $0 | $0 | $460 | $0 |
| SG&A Expenses | $474 | $503 | $460 | $507 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $23 | $26 | $21 | $25 |
| Operating Expenses | $549 | $587 | $537 | $590 |
| Operating Income | $334 | $305 | $231 | $267 |
| % Margin | 14.7% | 13.3% | 11.2% | 11.8% |
| Other Income/Exp. Net | -$37 | -$6 | -$14 | $108 |
| Pre-Tax Income | $297 | $299 | $217 | $375 |
| Tax Expense | $71 | $75 | $50 | $49 |
| Net Income | $227 | $226 | $169 | $326 |
| % Margin | 10% | 9.8% | 8.2% | 14.5% |
| EPS | 0.93 | 0.93 | 0.7 | 1.34 |
| % Growth | 0% | 32.9% | -47.8% | – |
| EPS Diluted | 0.93 | 0.93 | 0.69 | 1.34 |
| Weighted Avg Shares Out | 244 | 243 | 243 | 244 |
| Weighted Avg Shares Out Dil | 244 | 244 | 244 | 244 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $9 | $8 | $9 |
| Depreciation & Amortization | $141 | $145 | $145 | $142 |
| EBITDA | $444 | $453 | $370 | $526 |
| % Margin | 19.6% | 19.7% | 17.9% | 23.3% |